Content
and Copyright
i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
An autism-linked mutation disables phosphorylation control of UBE3A
-
Published Date:
Aug 06 2015
-
Publisher's site:
-
Source:Cell. 162(4):795-807.
-
[PDF-2.90 MB]
Details:
-
Alternative Title:Cell
-
Personal Author:
-
Description:Deletion of UBE3A causes the neurodevelopmental disorder Angelman syndrome (AS), while duplication or triplication of UBE3A is linked to autism. These genetic findings suggest that the ubiquitin ligase activity of UBE3A must be tightly maintained to promote normal brain development. Here, we found that protein kinase A (PKA) phosphorylates UBE3A in a region outside of the catalytic domain at residue T485 and inhibits UBE3A activity toward itself and other substrates. A de novo autism-linked missense mutation disrupts this phosphorylation site, causing enhanced UBE3A activity in vitro, enhanced substrate turnover in patient-derived cells, and excessive dendritic spine development in the brain. Our study identifies PKA as an upstream regulator of UBE3A activity and shows that an autism-linked mutation disrupts this phosphorylation control. Moreover, our findings implicate excessive UBE3A activity and the resulting synaptic dysfunction to autism pathogenesis.
-
Subject:
-
Pubmed ID:26255772
-
Pubmed Central ID:PMC4537845
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
image/jpeg
image/gif
image/jpeg
image/gif
image/jpeg
image/gif
image/jpeg
application/octet-stream
image/tiff
image/tiff
image/jpeg
image/tiff
image/tiff
image/tiff
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
image/gif
image/jpeg
image/gif
image/jpeg
image/gif
image/jpeg
image/gif
No Related Documents.
Email
CDC-INFO
